Oak Associates LTD United Therapeutics Corp Transaction History

Oak Associates LTD

  • $1.48 Billion
  • Q3 2024

A detailed history of Oak Associates LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Oak Associates LTD holds 7,515 shares of UTHR stock, worth $2.79 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
7,515
Previous 9,015 16.64%
Holding current value
$2.79 Million
Previous $2.87 Million 6.2%
% of portfolio
0.18%
Previous 0.19%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$311.04 - $363.55 $466,560 - $545,325
-1,500 Reduced 16.64%
7,515 $2.69 Million
Q2 2024

Aug 08, 2024
SELL
$228.26 - $319.04 $64,141 - $89,650
-281 Reduced 3.02%
9,015 $2.87 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $49,422 - $59,096
-230 Reduced 2.41%
9,296 $2.04 Million
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $22,241 - $26,065
105 Added 1.11%
9,526 $2.15 Million
Q1 2023

May 11, 2023
SELL
$212.99 - $276.17 $337,589 - $437,729
-1,585 Reduced 14.4%
9,421 $2.11 Million
Q4 2022

Feb 09, 2023
SELL
$205.95 - $280.43 $1.25 Million - $1.7 Million
-6,054 Reduced 35.49%
11,006 $3.06 Million
Q3 2022

Nov 09, 2022
SELL
$203.3 - $244.17 $40,660 - $48,834
-200 Reduced 1.16%
17,060 $3.57 Million
Q4 2021

Feb 10, 2022
SELL
$184.32 - $216.08 $64,512 - $75,628
-350 Reduced 1.99%
17,260 $3.73 Million
Q1 2021

May 13, 2021
SELL
$153.94 - $174.85 $658,093 - $747,483
-4,275 Reduced 19.53%
17,610 $2.95 Million
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $747,252 - $906,052
7,480 Added 51.93%
21,885 $2.21 Million
Q2 2020

Aug 11, 2020
BUY
$92.74 - $125.82 $236,950 - $321,470
2,555 Added 21.56%
14,405 $1.74 Million
Q1 2020

May 15, 2020
BUY
$79.39 - $115.35 $76,214 - $110,736
960 Added 8.82%
11,850 $1.12 Million
Q2 2019

Aug 09, 2019
BUY
$76.06 - $120.81 $472,712 - $750,834
6,215 Added 132.94%
10,890 $850,000
Q1 2019

May 09, 2019
BUY
$107.15 - $126.84 $11,250 - $13,318
105 Added 2.3%
4,675 $549,000
Q3 2018

Nov 13, 2018
BUY
$113.81 - $129.46 $2,845 - $3,236
25 Added 0.55%
4,570 $584,000
Q4 2017

Feb 08, 2018
BUY
$118.58 - $151.28 $156,525 - $199,689
1,320 Added 40.93%
4,545 $672,000
Q2 2017

Aug 18, 2017
BUY
N/A
3,225
3,225 $418,000

Others Institutions Holding UTHR

# of Institutions
676
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email